Access & Innovation
In the village of Gegema, Solomon Islands, health worker takes blood samples for rapid diagnostic tests. © Global Fund / John Rae
Timely access to vital malaria commodities can hasten elimination of this disease in the Asia-Pacific. These include diagnostic tools, treatments for drug-resistant malaria, and new tools for controlling mosquito populations.
But several barriers stand in the way. The region needs a better view of the pipeline of innovations and a clearer understanding of how existing and new commodities can support its malaria response. Unless physical and regulatory bottlenecks are eased, adoption of these new tools will be delayed, slowing down the prevention, detection and treatment of new cases.
We cut through today’s cluttered public health landscape, working to fast-track new solutions and unblock the bottlenecks which prevent life-saving solutions from reaching those in need.
APLMA facilitates partnerships to sustain access to new and existing tools to prevent, detect and treat malaria. We also focus on ensuring countries in the region have access to quality medicine and strive to provide universal health coverage.
This series of webinars gathers senior government officials and regulators from around the Asia-Pacific with manufacturers of malaria commodities and global health partners to discuss tools, innovations and strategies for advancing health security and eliminating malaria from the region.<br>
Vector Control Platform for Asia Pacific
Jointly created in 2018 by APLMA and Unitaid, VCAP offers the latest information on tools for controlling mosquito populations and how they are being deployed around the region to eradicate malaria and dengue.<br>
Regional Regulatory Partnership for Malaria Elimination (RRPME)
The RRPME is a capacity-building platform where national regulators can strengthen regional collaboration and share information on best practice with technical agencies, academics, donors, product development partnerships, and policy experts.<br>